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Ultrashort-lived iridium-191m (lr-191m, physical half-
life = 5.0 seconds) has been used in angiocardiography, 
primarily in pediatric patients. A theoretical obstacle to 
more widespread use of Ir-191m is the belief that its 
physical half-life is too short to permit evaluation of left 
ventricular function in adult patients. To evaluate its 
usefulness in adults, first pass ejection fractions of the 
left and right ventricles determined with use of Ir-191m 
and technetium-99m (Tc-99m) were compared in 33 adult 
patients. An osmium-191m ~ iridium-191m (Os-l91 ~ 
Ir-191m) generator was employed to deliver doses of 150 
to 250 mCi (5.5 to 9.2 G8q) of Ir-191m for intravenous 
injection. The whole body radiation absorbed dose with 
Ir-191m was 15 to 25 mrad. 
High quality angiocardiograms were obtained with 
both Tc-99m and Ir-191m. Total counts per image for 
the right ventricle were 51,000 ± 8,000 (mean ± SD) 
for Ir-191m and 30,000 ± 8,000 for Tc-99m. The left 
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ventricular counts were comparable for both radiotra-
cers (25,000 ± 7,000 for Ir-191m and 25,000 ± 8,000 
for Tc-99m). Right ventricular ejection fractions were 
similar: 44 ± 8% for Ir-191m and 47 ± 9% for Tc-
99m. The correlation coefficient was 0.93 with a stan-
dard deviation of the regression of 3.1 % ejection fraction 
units. The left ventricular ejection fractions were also 
similar: 45 ± 14% for Ir-191m and 46 ± 13% for Tc-
99m. The left ventricular ejection fraction correlation 
coefficient was 0.96 with a standard deviation of the 
regression of 3.7%. 
It is concluded that adequate Ir-191m first pass an-
giocardiograms are possible in adult patients, and that 
measurements of right and left ventricular ejection frac-
tions obtained by first pass stUdies with Tc-99m and Ir-
191m are similar. 
(J Am Coli CardioI1986;7:1295-302) 
First pass radionuclide angiocardiography has been used in 
the detection, localization and quantitation of intracardiac 
shunts and in the evaluation of both right and left ventricular 
function (l,2). Technetium-99m (Tc-99m) has been used 
widely and successfully over the past two decades in first 
pass radionuclide angiography and for gated blood pool 
scanning. In first pass studies, however, Tc-99m has the 
disadvantage of a relatively long physical half-life of 6 hours 
which does not allow for multiple sequential first pass stud-
ies within a short period of time. Multiple, rapid studies 
may be necessary to evaluate rapid changes in hemodynamic 
function, for example, during exercise or drug intervention. 
Although Tc-99m results in an acceptable radiation absorbed 
dose, with this tracer the patient is irradiated for a longer 
period of time than is necessary for first pass angiocardiog-
raphy (-30 seconds). In an attempt to increase the advan-
tages of first pass radionuclide angiocardiography, con sid-
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erable interest has recently been directed toward the 
development of generators that produce radionuclides with 
a much shorter physical half-life (ultrashort-lived radio-
nuclides) (3-10). 
Ultrashort-lived radionuclides that can be produced from 
generator systems for the evaluation of cardiovascular func-
tion include Ir-191m (half-life = 5.0 seconds) (3-5), gold-
195m (half-life = 30.5 seconds) (6-8) and tantalum-l78 
(half-life = 9.3 minutes) (9,10). Iridium-191m angiocar-
diography has been used effectively in the detection of shunts 
in pediatric patients (II), and has been employed in prelim-
inary evaluation of left ventricular function in adults (12,13). 
Gold-195m has been used to evaluate left ventricular func-
tion in adults (6,8,14,15) and, in rapid sequence angiocar-
diography, to evaluate the effect of exercise and cold pressor 
stimulation on cardiac function (6, 16-20). 
Although its extremely short half-life makes Ir-191 m well 
suited for the evaluation of children (5,11), it has not been 
clear whether this radiotracer could be used successfully to 
evaluate both right and left ventricular function in adult 
patients (12,13). Of particular concern has been the eval-
uation of left ventricular function in patients with prolonged 
circulatory transit times, as in congestive heart failure. 
This investigation was designed to test the hypothesis 
that Ir-191 m may be useful in determining both right and 
left ventricular ejection fractions in adults. To this end, 
radionuclide angiocardiograms obtained with Ir -191 m and 
Tc-99m in the same patients and under the same physiologic 
conditions were compared. 
Methods 
Study patients. Thirty-three patients (aged 26 to 93 
years, mean 61) referred to the Division of Nuclear Medicine 
of the Beth Israel Hospital in Boston for evaluation of ven-
tricular function were studied with first pass radionuclide 
angiocardiography using Ir-191 m and Tc-99m, sequentially. 
The protocol was approved by the Beth Israel Hospital Com-
mittee on Clinical Investigation. Informed consent was ob-
tained from each patient before the study. There were no 
adverse effects or complications secondary to the admin-
istration of Ir - I 91 m solution from the generator. 
Radionuclide angiographic procedure. Radiotracer in-
jections were made either in a butterfly needle into an ex-
ternal jugular vein or through a thin catheter placed into a 
subclavian vein using the antecubital route. The intravenous 
catheter was not essential for Ir-191 m angiography, but it 
was used in some patients to facilitate the maintenance of 
an intravenous route for the two sequential studies in this 
investigation. As with all first pass studies, attention to 
delivery of a rapid (l to 3 seconds) and compact (I to 2 
m!) bolus of tracer was important in obtaining images of 
good quality and temporal resolution. The Ir -191 m angio-
cardiogram was performed first, followed by a Tc-99m study 
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within 10 minutes. The patient was maintained in the same 
position for both studies. 
Radiotracers. The osmium-191 ~ iridium-191 m (Os-
191 ~ Ir-191m) radionuclide generators used in this study 
were developed and prepared in the Division of Nuclear 
Medicine at the Children's Hospital in Boston, as previously 
described (3,4). The Os-191 parent radionuclide, with a 
physical half-life of 15 days, was prepared by neutron ir-
radiation of enriched (>96%) Os-190 metal. Os-191 activity 
produced by 3 days of irradiation at a neutron flux of 2.5 
x 1015 neutrons/cm per second was 250 mCi/mg (9.25 
GBq/mg). The generators typically contained 800 mCi (30 
GBq) of Os-191 at the time of production. All generators 
were sterile and pyrogen-free. 
Iridium-191 m yield was determined by eluting the gen-
erator into a disposable tube placed in a dose calibrator 
(Capintec, Radioisotope Calibrator CRC-5R). The maximal 
reading obtained was corrected for radioactive decay. After 
Ir-191m was allowed to decay, the eluent was counted a 
second time to determine Os-191 breakthrough. The Ir-
191 m yield of the generators ranged from 20 to 25 % per 2 
ml of eluent, expressed as percent of the total Os-19 I ac-
tivity in the column. The Os-191 breakthrough in the same 
sample of eluent was 5 to 7 x 10 - 3% per 2 m!. The injected 
dose of Ir- I 91 m per study, calibrated at the beginning of 
the elution, ranged from 150 to 250 mCi (5.5 to 9.2 GBq). 
The eluate from the generator, at pH 1, was buffered with 
0.05 M disodium hydrogen phosphate to pH 3.5 during 
injection. The eluate from the generator was delivered di-
rectly into the patient by intravenous injection. The buffer 
solution served also to flush the bolus rapidly into the pa-
tient. The whole body radiation absorbed dose is 15 to 25 
mrad (0.15 to 0.25 mGy) and is due largely to the Os-191 
breakthrough. The estimated dose of the vein receiving the 
injection is about 0.4 rad. For the second angiocardiogram, 
20 mCi of Tc-99m as sodium pertechnetate was used. 
Data recording and analysis. The radionuclide angio-
cardiograms were recorded using a conventional gamma 
scintillation camera (Technicare, large field of view) with 
a low energy, slant hole (30°), medium resolution, medium 
sensitivity collimator. With the patient supine, the colli-
mator was placed flat over the chest with the holes pointing 
so as to obtain a right anterior oblique projection. Data were 
stored and analyzed with a digital computer system (Gamma-
II, Digital Equipment Corp.). Imaging of Ir -191 m was 
carried out using 20% windows centered on both the 65 and 
129 keY photopeaks. The angiocardiograms were recorded 
for 25 seconds using list mode and were reformatted 
into series of images in a 64 x 64 matrix format at 25 
frames/so 
The computer analysis consisted of identifying regions 
of interest corresponding to the right and left ventricles. 
The time-activity curves from these regions were filtered to 
remove high frequency noise. Cardiac cycles during the 
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dextro- and levophases of the study were selected for anal-
ysis, The peaks and valleys of the selected series of cardiac 
cycles, corresponding to end-diastole and end-systole, re-
spectively, were identified by a computer program using a 
variable threshold method. Images from the peaks were 
added to form an image corresponding to end-diastole, whereas 
the same number of contemporary images from the valleys 
were added to form an image corresponding to end-systole. 
This process was carried out for the right and left ventricles. 
Separate regions of interest were then outlined by the 
operator around the right and left ventricular silhouettes 
on the end-systolic and end-diastolic images. Ventricular 
ejection fraction was calculated as follows: end-diastolic 
counts - end-systolic counts/end-diastolic counts. 
Statistical analysis. The means and standard deviations 
were calculated for the count rate during the right and left 
heart phases of the Ir-191 m and the Tc-99m studies. Right 
and left ventricular ejection fractions were calculated for 
the Ir -191 m and the Tc-99m studies by two observers, These 
values were tested for normal distribution using the W sta-
tistic (21). For both right and left ventricular ejection frac-
tions this led to three sources of variation, Ir-191m/Tc-99m, 
observer and patient. Three-way analysis of variance was 
used to assess the contribution of each source to the results. 
The calculated ejection fractions from the two observers 
were averaged to give an Ir-191m and a Tc-99m ejection 
fraction for each patient. These values were compared by 
regression analysis, and correlation coefficients and standard 
deviations of the regression were calculated. 
Results 
Mean count rates. Thirty-three patients had sequential 
Ir-191m and Tc-99m radionuclide angiocardiograms. Re-
sults for both the right and left ventricular phases are shown 
in Table 1. The mean count rate for the right ventricular 
phase was 32,500 counts/s (range 21,800 to 52.300) for Tc-
99m and 50,700 counts/s (range 36,900 to 66,700) for Ir-
191m. 
The mean count rate for the left ventricular phase was 
24,700 counts/s (range 16,200 to 48,700) for Tc-99m com-
pared with 23,400 counts/s (range 15,900 to 42,300) for Ir-
191 m. Thus, although there was a substantial fall in counts 
between the right and left ventricular phases with Ir-19Im, 
the counts in the left ventricular phase were similar for Ir-
191m and Tc-99m. 
An example of first pass radionuclide angiocardiograms 
obtained with Ir-191 m and Tc-99m in the same patient is 
shown in Figure I. The right and left ventricular images 
with the two tracers are of similar quality. 
Right ventricular ejection fraction. Figure 2 shows an 
example of Ir-191 m and Tc-99m images during end-diastole 
and end-systole used in the calculation of right ventricular 
ejection fraction in one patient. The calculated ejection frac-
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Table 1. Total Counts Per Second (in thousands) in 33 Patients 
Indium-191 m 
PatIent 
TechnetlUm-99m 
Count 
No RV LV RV LV Loss (%) 
39.1 29.9 64.5 35.1 46 
2 52.3 48.7 667 38.9 42 
3 229 16.3 537 15.1 72 
4 26.3 180 56.2 18.5 67 
5 35.1 30.8 53.3 346 35 
6 325 26.5 441 16.2 63 
7 36.0 31.4 49.1 24.0 51 
8 23.5 17.7 36.9 16.7 54 
9 21 3 16.2 54 I 27.9 48 
10 27.9 214 54.2 21 5 60 
11 37.1 33.0 56.2 17.6 69 
12 276 22.8 469 18.3 61 
13 26.7 183 43.9 157 64 
14 303 24.8 502 18.8 63 
15 24.7 21.7 46.0 23.5 49 
16 28.6 23 1 37.0 15.9 57 
17 31 0 23.0 52.2 291 44 
18 357 29.7 597 42.3 29 
19 34.5 26.0 57.3 23.2 58 
20 29.6 237 47.4 13.0 73 
21 252 18.5 55.7 23 1 59 
22 37.1 31.5 545 22 1 59 
23 293 23.0 567 192 66 
24 328 27.2 51 8 18.1 63 
25 44.3 369 55.8 23 I 59 
26 37.1 31.4 54.4 27.2 50 
27 289 21.7 499 168 66 
28 43.5 36.2 400 10.1 75 
29 30.5 21.8 48.8 270 45 
30 262 21.1 579 235 57 
31 30.3 245 47 I 24.4 46 
32 43.6 40.7 53.7 384 58 
33 36.5 29.1 606 22.7 60 
Mean 30.5 25.1 51.2 25.1 
±SD ±8.1 ±8.0 ±8.0 ±7 
LV = left ventricular phase; RV = nght ventncu1ar phase: SD = 
standard deVIation of the mean. pooled data. 
tion in this example was 34% with Ir-191m and 36% with 
Tc-99m. Values for right ventricular ejection fraction, cal-
culated by two observers from the same data, are shown in 
Table 2. Because the ejection fractions for each observer 
were tested and found to be normally distributed (21), par-
ametric statistical tests were applied. Analysis of variance 
revealed that the ejection fractions calculated by the two 
observers were not significantly different. Therefore, these 
results were averaged and results were calculated from the 
averages. The calculated ejection fractions for the right ven-
tricle were 44 ± 8% (mean ± SD) with Ir-191m and 47 
± 9% with Tc-99m. A paired t test was performed on these 
data, which showed a small but significant difference for 
the two radiotracers (p < 0.001). 
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Figure 1. Radionuclide angiocardiography 10 the same patient 
comparing iridium-191 m (IR) (left) and technetium-99m (TC) 
(right). The studies are displayed at one frame/2 seconds. 
Figure 3 shows the relation between right ventricular 
ejection fractions from Tc-99m and Ir-191m studies. The 
correlation coefficient was 0.93 and the standard deviation 
of the regression was 3.1 % ejection fraction units (p < 
0.001). 
Figure 2. Comparison of right ventricular end-diastolic (ED) and 
end-systolic (ES) images utilized in the calculation of ejection 
fractions from iridium-191 m and technetium-99m in the same pa-
tient. 
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Table 2. Right Ventricular Ejection Fraction Utilizing 
Iridium-191 m and Technetium-99m 
PatIent 
No 
2 
3 
4 
5 
6 
7 
8 
9 
10 
II 
12 
13 
14 
15 
16 
I7 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
Mean 
±SO 
44 
39 
60 
43 
65 
49 
37 
41 
44 
39 
27 
41 
44 
50 
51 
54 
57 
56 
40 
52 
47 
45 
42 
39 
52 
55 
35 
26 
41 
31 
52 
41 
39 
Iridium-191 m 
2 Mean 
39 
35 
57 
38 
55 
47 
40 
41 
41 
41 
31 
39 
37 
57 
44 
54 
55 
53 
39 
52 
50 
47 
44 
43 
49 
52 
37 
25 
44 
30 
50 
43 
41 
43 
40 
57 
41 
59 
47 
39 
39 
45 
39 
29 
38 
39 
51 
42 
53 
57 
54 
40 
50 
49 
46 
43 
41 
51 
54 
36 
26 
43 
31 
51 
42 
40 
44 
±8 
42 
48 
64 
41 
62 
51 
40 
38 
44 
43 
31 
44 
44 
57 
51 
58 
59 
60 
41 
47 
55 
44 
42 
37 
53 
59 
40 
26 
44 
36 
53 
44 
43 
TechnetlUm-99m 
2 Mean 
46 
49 
67 
37 
62 
55 
37 
41 
46 
40 
33 
34 
42 
62 
48 
63 
58 
53 
40 
45 
53 
42 
45 
40 
47 
62 
42 
30 
46 
35 
55 
40 
41 
45 
48 
63 
43 
62 
50 
44 
39 
43 
40 
32 
41 
40 
57 
52 
60 
59 
57 
41 
48 
54 
43 
45 
39 
50 
61 
41 
28 
45 
35 
54 
42 
42 
47 
±9 
I = Observer I; 2 = observer 2; SO standard deviation of the 
mean, pooled data. 
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Tc-99m 
Figure 3. Comparison of right ventricular ejection fractions (RVEF) 
from studies obtained in the same patient using technetium-99m 
and iridium-191m. 
Left ventricular ejection fraction. An example of im-
ages obtained during the left ventricular phase with each 
radiotracer is shown in Figure 4. The images with the two 
tracers appear to be of similar quality and spatial resolution. 
The calculated left ventricular ejection fractions were similar 
(37% for both Ir-191m and Tc-99m). 
Calculations of left ventricular ejection fraction for all 
patients are shown in Table 3. As with right ventricular 
ejection fraction, the left ventricular ejection fractions were 
normally distributed and there was no difference between 
the results from the two observers. Left ventricular ejection 
fraction ranged from 14 to 67% using Ir-191m and 12 to 
74% using Tc-99m and averaged 45 ± 14% with Ir-191m 
Figure 4. Comparison of left ventricular end-diastolic 
(ED) and end-systolic (ES) images utilized in the cal-
culation of ejection fractions from technetium-99m and 
iridium-99m in the same patient. 
Ir-191m 
Tc-99m 
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and 46 ± 13% with Tc-99m. The paired t test again showed 
a small but statistically significant difference (p < 0.05) in 
the calculation from the two radiotracers. 
The relation between the left ventricular ejection fractions 
obtained with Ir-191 m and Tc-99m is illustrated in Figure 
5. The correlation coefficient was 0,96 with a standard de-
viation of the regression of 3.7% ejection fraction units 
(p < 0.001), 
Discussion 
The purpose of this investigation was to evaluate the 
usefulness of the ultrashort-lived radionuclide Ir-191 m in 
the determination of right and left ventricular function in 
adults by first pass angiocardiography. Comparing sequen-
tial studies carried out with Ir-191 m and Tc-99m in the same 
patient and under the same experimental conditions, we 
found excellent correlations of both right ventricular ejection 
fractions (r = 0.93, standard deviation of the regression 
3.1 % ejection fraction units) and left ventricular ejection 
fractions (r = 0.96, standard deviation of the regression 
3.7%). Qualitatively, the left ventricular images obtained 
with Ir-191m were similar to those obtained with Tc-99m, 
These results demonstrate that lr-191 m may be used in place 
of Tc-99m to evaluate both right and left ventricular ejection 
fraction in adults, 
Advantages of ultrashort-lived radionuclides in car-
diac studies. Although Tc-99m is used successfully in a 
wide variety of clinical diagnostic applications, it suffers 
from several limitations when used with first pass radio-
nuclide angiocardiography. These limitations arise from its 
ED ES 
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Table 3. Left Ventricular Ejection Fraction Utilizmg 
Iridium-191 m and Technetium-99m 
Patient IndIUm-191m TechnetlUm-99m 
No. 2 Mean 2 Mean 
48 49 48 43 43 43 
2 50 50 52 57 62 58 
3 40 39 39 39 37 38 
4 45 33 41 49 40 45 
5 68 62 62 66 61 64 
6 47 51 51 52 53 50 
7 49 50 49 52 52 49 
8 45 43 46 47 44 45 
9 32 25 31 38 41 35 
10 55 57 56 56 53 54 
II 38 38 40 41 38 40 
12 55 53 52 51 59 56 
13 45 41 45 43 41 46 
14 34 33 37 40 41 40 
15 36 31 36 34 33 40 
16 59 54 57 59 61 59 
17 54 63 57 52 60 58 
18 61 63 62 69 67 68 
19 53 53 53 50 50 50 
20 28 30 29 30 30 30 
21 63 61 62 63 65 64 
22 27 30 29 27 30 28 
23 68 66 67 66 63 65 
24 33 35 34 39 38 39 
25 62 66 64 60 63 62 
26 44 45 45 47 51 49 
27 42 40 41 47 45 46 
28 16 17 17 16 20 18 
29 51 55 53 52 50 51 
30 33 35 34 36 38 37 
31 44 42 43 49 45 47 
32 52 55 54 55 52 53 
33 13 15 14 10 13 12 
Mean 45 47 
±SD ± 14 ±9 
Abbreviations as in Table 2. 
6 hour physical half-life, which is substantially longer than 
the approximately 30 seconds required to record a radio-
nuclide angiocardiogram. The patient is, therefore, irradi-
ated for a much longer period than is necessary for the study. 
Serial imaging with this tracer is marred because of high 
background activity. 
Major advantages of Ir-191m include lower patient ra-
diation exposure and the possibility of performing serial 
studies within a short time. Another significant advantage 
oflr-191m is the ability to evaluate rapid changes in cardiac 
function. Rapid changes induced by exercise and cold pres-
sor stimulation (20) have been studied with gold-195m, and 
there is every reason to believe that the same can be done 
with Ir-191m. Ultrashort-lived radionuclides may also be 
used to evaluate ventricular function simultaneously with 
thallium-201 perfusion imaging (17). 
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Figure 5. Comparison of left ventricular ejection fractions (L VEF) 
from studies obtained using technetium-99m and iridium-191 m as 
imaging agents in the same patients. 
Comparison among ultrashort-lived radionuclides. 
The requirements for an ultrashort-lived radionuclide 
suitable for the first pass radionuclide angiocardiography 
are quite strict. To achieve routine clinical availability, the 
ultrashort-lived radionuclide should be generator-produced 
with a parent radionuclide of sufficiently long half-life to 
provide a useful generator shelf life of 1 to 2 weeks. The 
parent radionuclide should decay with a high yield of the 
daughter radionuclide. It should not emit high energy pho-
tons that would present a shielding problem. The generator 
should be able to provide high radiochemical yield of the 
ultrashort-lived radionuclide. The daughter radionuclide must 
be of a reasonable physical half-life for use in angiocar-
diography. In addition, the ultrashort-lived radionuclide should 
produce a high yield of photons of an energy suitable for 
detection by gamma cameras. Because first pass studies 
require a compact bolus of high specific activity radio-
nuclide, it must be possible to elute the generator rapidly 
(within 1 to 2 seconds) and directly into the patient in a 
small volume (I to 2 ml) of nontoxic solution. 
Although several generator systems have been proposed 
for this application, none are routinely available. The mer-
cury-195m (half-life = 40 hours) ~ gold-195m (half-life 
= 31 seconds) (6-8,21,22) generator has received a great 
deal of attention, but suffers from several serious limita-
tions, primarily because of the mercury-195m (Hg-195m) 
decay scheme. Only half the Hg-195m decays to gold-195m 
(Au-195m), whereas the remainder decays to Hg-195 which 
in tum decays directly to Au-195 (half-life = 184 days) 
rather than to Au-195m. The photon yield available for 
imaging is, therefore, only 34% of the total Hg-195m ac-
tivity. In addition, the Au-195 that is produced from both 
Hg-195 and Au-195m decay must be eluted from the gen-
erator and discarded before clinical use to minimize patient 
radiation dose. Moreover, the relatively short half-life of 
the Hg -195m limits the useful life of the generator to 2 to 
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3 days. Production of Hg-195m is also a problem, as ap-
proximately twice as much Hg-195 as Hg-195m is produced. 
Although the physical half-life of Hg-195 is only 9 hours 
and it can, therefore, be allowed to decay, waiting for the 
Hg-195 to decay decreases the yield of desired Hg-195m. 
The major advantage of this system is the nearly ideal phys-
ical half-life of Au-195m (30 seconds). 
Another potential generator system is cadmium-l09 (half-
life = 464 days) ~ silver-109m (half-life = 40 seconds) 
(23). The very long half-life of cadmium-109 (Cd-109) leads 
to the strict requirement of extremely low breakthrough of 
the parent radionuclide. Another disadvantage of this system 
is the very low photon yield of silver-109m (4%). This leads, 
in tum, to the requirement for a very high level of activity 
of Cd-109 in the generator to provide reasonable photon 
flux, thereby compounding the breakthrough problem. 
The rubidium-81 (half-life = 4.6 hours) ~ krypton-81m 
(half-life = 13 seconds) generator provides a high yield of 
krypton-81m (Kr-81m), which in tum has a high photon 
yield (67%). The limitations of this generator arise from the 
short half-life of the rubidium-81, which imposes severe 
restrictions on processing and shipping, and the fact that 
intravenous Kr-81 m dissolved in water is quantitatively 
eliminated by the lungs in the first pass, thus precluding 
studies of the left side of the heart (24). 
Osmium-191 (half-life = 15.4 days) ~ lr-191m (half-
life = 5 seconds) has a potential generator shelf life of 2 
to 3 weeks. Osmium-191 decays by beta emission to Ir-
191m, which in tum decays to isomeric transition with the 
production of 129 keY gamma rays (26%). The internal 
conversion process also gives rise to 65 keY X-rays (60%) 
that may also be used for imaging. The beta decay of Os-
191 imposes no additional shielding requirements beyond 
those of the Ir -191 m daughter so that the generator can be 
shielded with a small amount of lead, making the entire 
generator lightweight and easily portable. The photopeaks 
(129 and 65 keY) have energies that may be used with either 
a standard Anger gamma camera, a multicrystal camera or 
the multiwire gamma camera (13). Osmium-191 is produced 
by neutron irradiation of isotopically enriched Os-190 (>95%) 
and is, consequently, available at more reasonable cost than 
cyclotron-produced radioisotopes such as Hg-195. 
Thus, the Os-191 ~ Ir-191m generator affords many of 
the ideal properties: good shelf life, portability, rapid reuse 
and reasonable decay scheme. The only potential drawback 
of this system may be the extremely short half-life of Ir-
191m. Although it had been assumed that the 5.0 second 
half-life precluded the use ofIr-19lm in adults (23,25), the 
present study demonstrates that results at least similar to 
those obtained with Tc-99m can be obtained for both the 
right and left ventricle. 
The whole body absorbed radiation dose from an ad-
ministered dose of 150 to 250 mCi of Ir-191m from the 
generator is 15 to 25 mrad and is principally due to Os-191 
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breakthrough. This should be compared with a whole body 
dose of 240 mrad and an absorbed dose to the lower intestine 
of 4,000 mrad for 20 mCi of Tc-99m as sodium pertech-
netate. Improved Os-191 ~ Ir-191m generator systems with 
lower Os-191 breakthrough, higher Ir-191m yield, or both, 
will result in a dramatic further reduction in dose. 
Conclusion. This combination of reasonable generator 
shelf life, portability, extremely low patient radiation dose 
and the ability to evaluate both left and right ventricular 
function in adults makes Ir-191m a very promising radio-
tracer for first pass radio nuclide angiography, particularly 
in the evaluation of rapid cardiovascular changes such as 
those observed in response to drugs or exercise. 
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